| Lilly and Nimbus Forge US$1.3 B Collaboration to Develop Oral Obesity Treatment |
Abstract
html
pdf
|
|
Hitesh Udar |
|
| Madrigal Inks US$50 M Deal with Pfizer for DGAT-2 inhibitor Ervogastat for the Treatment of MASH |
Abstract
html
pdf
|
|
Naini Anand |
|
| BioMarin Expands Rare Disease Portfolio with US$4.8 B Acquisition of Amicus Therapeutics |
Abstract
html
pdf
|
|
Naini Anand |
|
| Lilly to Acquire Ventyx Biosciences for US$1.2 B to Advance Oral Therapies Targeting Inflammatory-Mediated Diseases |
Abstract
html
pdf
|
|
Naini Anand |
|
| GSK to Acquire RAPT Therapeutics for up to US$2.2 B |
Abstract
html
pdf
|
|
Ayush Saxena |
|
